Once weekly subcutaneous administration of erythropoietin in haemodialysis patient
JPMA-Journal of Pakistan Medical Association. 1994; 44 (4): 88-90
em Inglês
| IMEMR
| ID: emr-33082
ABSTRACT
Twenty-five anaemic patients of End Stage Renal Disease [ESRD] on maintenance haemodialysis at the Kidney Centre were studied. Recombinant human erythropoietin [EPO] 50-units/kg body weight was given once a week subcutaneously to see the response to therapy. In 21 cases haemoglobin increased significantly from 7.5 to 9.5 g/dl and haematocrit from 23 to 30.5 L/L with success rate of 84% and marked improvement in their quality of life. Once a week subcutaneous administration of erythropoietin is convenient and cost effective in reversing renal anaemia with minimal complications
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Eritropoetina
/
Anemia
/
Falência Renal Crônica
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
J. Pak. Med. Assoc.
Ano de publicação:
1994
Similares
MEDLINE
...
LILACS
LIS